Cargando…
BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB Signaling Pathway through Activating GABA(B) Receptor
The gamma-aminobutyric acid type B (GABA(B)) receptor may participate in the development of diabetic neuropathic pain (DNP). BHF177 serves as a positive allosteric modulator of the GABA(B) receptor. In the current study, we sought to study the role of the BHF177-GABA(B) receptor in DNP and its under...
Autores principales: | Liu, Boyu, Guan, Fengxi, Zhao, Jiapeng, Niu, Yao, Jiang, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691330/ https://www.ncbi.nlm.nih.gov/pubmed/36439691 http://dx.doi.org/10.1155/2022/4661519 |
Ejemplares similares
-
The Role of CaMKII and ERK Signaling in Addiction
por: Jia, Wenbin, et al.
Publicado: (2021) -
Tilianin Ameliorates Cognitive Dysfunction and Neuronal Damage in Rats with Vascular Dementia via p-CaMKII/ERK/CREB and ox-CaMKII-Dependent MAPK/NF-κB Pathways
por: Jiang, Hailun, et al.
Publicado: (2021) -
HCN2 contributes to oxaliplatin-induced neuropathic pain through activation of the CaMKII/CREB cascade in spinal neurons
por: Liu, Xiaoyu, et al.
Publicado: (2018) -
The κ-Opioid Receptor Agonist U50488H Ameliorates Neuropathic Pain Through the Ca(2+)/CaMKII/CREB Pathway in Rats
por: Zhang, Xiao-Min, et al.
Publicado: (2022) -
CaMKII points the way
por: Leslie, Mitch
Publicado: (2012)